![Jan-Willem den Toom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jan-Willem den Toom
Directeur Général chez
Ribo Technologies BV
Profil
Jan Willem den Toom is a General Manager at Heartstream Health BV.
He has a Master’s degree in Economics and many years’ experience in pharmaceuticals and biotechnology (prescription medicines, functional foods and bulk antibiotics).
He has business experience in Europe, the U.S.
and Asia.
At Sandoz he launched Isostar® and Modifast® and established Sandoz country organization, including manufacturing facilities, in Indonesia.
At Gist-Brocades/ DSM he established the industrial division as world leader in production of bulk antibiotics.
Postes actifs de Jan-Willem den Toom
| Sociétés | Poste | Début |
|---|---|---|
Ribo Technologies BV
 Ribo Technologies BV Medical SpecialtiesHealth Technology Provides microbial diagnostic solutions | Directeur Général | - |
Anciens postes connus de Jan-Willem den Toom
| Sociétés | Poste | Fin |
|---|---|---|
Heartstream Capital BV
 Heartstream Capital BV Investment ManagersFinance Heartstream Capital is a manager which seeks an active role in companies with operating in the healthcare sector. They provide capital for early and late-stage ventures located in Europe. They take a minimum stake of 5%. Their typical exit strategy involves IPOs or trade sales within five years. | Corporate Officer/Principal | 01/01/2008 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
1
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Ribo Technologies BV
Ribo Technologies BV Medical SpecialtiesHealth Technology Provides microbial diagnostic solutions | Health Technology |
Heartstream Capital BV
Heartstream Capital BV Investment ManagersFinance Heartstream Capital is a manager which seeks an active role in companies with operating in the healthcare sector. They provide capital for early and late-stage ventures located in Europe. They take a minimum stake of 5%. Their typical exit strategy involves IPOs or trade sales within five years. | Finance |
